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Why a protein switches sides during translation
M
ultipass transmembrane pro-
teins weave back and forth 
across the lipid bilayer. Two 
papers by Lin et al. (1, 2) reveal that infor-
mation encoded within the proteins helps 
defi  ne this alternating pattern.
A protein destined for the plasma 
membrane usually starts out in the ER. 
As translation of the protein’s mRNA 
begins, the newly made polypeptide 
slips into the ER membrane. As the pro-
tein elongates, it crisscrosses the mem-
brane so that its hydrophilic loops are 
properly oriented either outside or in-
side the ER. A cell accomplishes this 
nifty stitching without allowing calcium 
ions to spill from the ER. During trans-
lation, a ribosome sits on a translocon (3), 
a pore that can open and close. However, 
researchers don’t understand how the ribo-
some–translocon complex prevents calci-
um leaks. Another important question, 
says Arthur Johnson, senior author on 
both papers, “is how the 
system alternates delivery 
of these loops to opposite 
sides of the ER membrane 
at the proper time.”
Previous studies on 
proteins with a single 
transmembrane segment 
(TMS) suggest that trans-
lation of that segment 
causes the nascent chain 
to reverse direction (4). But it was un-
clear whether this mechanism would 
enable a growing protein chain to feed 
through the membrane multiple times. 
To find out, Lin et al. allowed ribo-
somes to translate mRNA snippets that 
coded for two or three TMSs. The re-
searchers tracked the resulting protein 
chains by tagging them with a fl  uorescent 
dye that goes dark when it encounters an 
iodide ion. By introducing iodide ions 
into the cytoplasm or the ER, the team 
could determine which side of the ER 
membrane the growing strands were ex-
posed to. Each time a TMS was translated, 
the elongating chain reversed course, 
growing toward the cytosol instead of 
the ER interior or vice versa. Altering a 
TMS’s amino acid sequence, length, or 
orientation didn’t prevent it from caus-
ing a reversal, nor did changing how 
hydrophobic it was.
Translation of a TMS triggers a struc-
tural shift in the ribosome–translocon 
complex, the researchers 
conclude. When the ribo-
some sits fl  ush  on  the 
translocon, which has its 
pore open, the nascent 
chain feeds into the ER. 
Translation of a TMS 
causes the pore to close 
and the ribosome to 
morph into an open state 
that directs the growing 
chain into the cytosol. The next TMS to 
come along prods the ribosome to slam 
down on the translocon and the pore to 
reopen, so that the nascent chain once 
again protrudes into the ER interior. This 
mechanism positions the growing pro-
tein’s hydrophilic loops on one side of 
the ER membrane or the other without 
causing a calcium leak.
In their second study, Lin et al. investi-
gated how a TMS triggers these changes. 
Shortly after being translated, each TMS 
slides into a tunnel in the ribosome that is 
lined by ribosomal RNA and a few pro-
teins. The researchers discovered that, 
when the segment is opposite a protein in 
the tunnel called L17, the TMS coils into 
an -helix. Whenever this happened, the 
growing protein chain at the membrane 
switched its destination, suggesting that 
TMS folding triggers the ribosome–trans-
locon complex to reshape. Supporting 
that conclusion, Lin et al. showed that a 
soluble protein, the hormone prolactin, 
does not fold near L17 and does not warp 
the complex.
The findings indicate that a trans-
membrane protein controls when its 
loops reverse course. TMSs trigger the 
ribosome–translocon complex to contort 
and enable the lengthening protein to 
switch direction. “All of these structural 
changes are happening while the protein 
is still being made,” says Johnson. A ques-
tion the researchers would like to pursue 
is how TMS folding leads to alterations in 
the ribosome and translocon. They specu-
late that L17 and ribosomal RNA might 
help communicate the TMS shape change 
from the ribosome tunnel to the surface 
of the organelle.
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(Left to right) Arthur Johnson, Pen-Jen Lin, Candice Jongsma, Shuren Liao, and Martin Pool reveal 
how nascent transmembrane proteins snake back and forth across the ER membrane. As shown 
in the schematic diagram, their ﬁ  ndings suggest that the ribosome (blue) initially ﬁ  ts snugly on 
top of the translocon (yellow) so that the newly made protein chain unreels into the interior of 
the ER (left). But the translation of a transmembrane segment (TMS1) opens up the ribosome and 
shuts the translocon pore, redirecting the nascent chain toward the cytoplasm (center). The system 
switches back when a second transmembrane segment (TMS2) is translated (right).
“All of these 
structural 
changes are 
happening while 
the protein is still 
being made.”
Sequences within growing transmembrane proteins determine when 
loops reverse direction to cross the ER membrane.
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